Since the first reports in December 2019, the newly emerged respiratory coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has become a pandemic with widespread community transmission in many countries. Because of the global spread of a newly emerged virus, and no antivirals or vaccines being available, the World Health Organization and many public health agencies internationally advise individuals to stay at home if either they or a household member experiences symptoms of COVID-19, to mitigate the community spread of the pandemic SARS-CoV-2 virus \[[@CIT0001]\].

As COVID-19 symptoms are nonspecific, not all individuals staying at home will be infected, and testing workers for SARS-CoV-2 would enable uninfected individuals to remain available for work \[[@CIT0005]\]. This is particularly important for workers whose occupational roles are critical to the functioning of society and the COVID-19 response (so-called "key workers"), including in health and social care, transport, education, public safety, government, utilities, and food production and delivery \[[@CIT0008], [@CIT0009]\]. Additionally, asymptomatic SARS-CoV-2 likely contributes to transmission \[[@CIT0010]\], which could be reduced by testing. Capacity for (extensive) testing may be limited \[[@CIT0011], [@CIT0012]\], however, and is also required by patients. Targeted testing and optimizing testing strategies are thus important internationally.

For key workers, the crucial question faced is whether to concentrate on testing staff for infection with SARS-CoV-2 who present as cases with COVID-19--like symptoms, staff who are asymptomatic but quarantining at home, or all staff regardless of symptom status or quarantine. We used a decision-analytic model to explore the impact of different testing strategies for SARS-CoV-2 infection by swabbing and reverse transcriptase--polymerase chain reaction (RT-PCR) on (1) the duration key workers such as healthcare staff spend in household isolation, (2) the numbers of staff at work who may spread SARS-CoV-2, (3) the testing accuracy (ie, the proportion of true positive and true negative results among all tests), and (4) the required numbers of tests.

METHODS {#s1}
=======

Epidemiological Data Informing the Decision-Analytic Model {#s2}
----------------------------------------------------------

We varied the proportion of key workers and their households with infectious and detectable SARS-CoV-2 infection at any given time between 0.1% and 20% (base value: 2% \[[@CIT0013]\]), reflecting different levels of mitigation and including the expected prevalence of 5.8% when an assumed 80% of the workers and household members become infected over the course of a 3-month epidemic, with a mean duration of infectiousness of 6.5 days \[[@CIT0014]\] (0.80 × 6.5 days/90 days = 0.058). We considered between 10% and 80% of SARS-CoV-2 infections to be asymptomatic or subclinical (base value: 18%) \[[@CIT0010]\], between 10% and 80% of cases to involve COVID-19--like symptoms of a high fever (base value: 47%) \[[@CIT0011]\], and between 0% and 20% of infections to be too severe for isolation at home and to require hospitalization (base value: 4.4%) \[[@CIT0014]\]. Another 10% of workers are assumed to experience COVID-19--like symptoms from other respiratory illnesses \[[@CIT0006]\], of whom 2% are assumed to become hospitalized \[[@CIT0015]\]. Furthermore, key workers without symptoms but with symptomatic household contacts need to self-isolate (49% of key workers in the United Kingdom live with children and a partner \[[@CIT0009]\]; the rates of illness in household members and key workers were assumed to be the same). RT-PCR test sensitivity (proportion of infected individuals testing positive) was varied between 60% and 95% (with an assumed base value of 75%), and specificity (proportion of uninfected individuals testing negative) was varied between 90% and 100% (base value: 90%) \[[@CIT0016], [@CIT0017]\]. All input parameters of the model were varied in sensitivity analyses.

Strategies of Testing for SARS-CoV-2 Infection in Key Workers {#s3}
-------------------------------------------------------------

Our static decision-analytic model followed 1000 key workers to compare the baseline strategy of no testing and self-isolating based on COVID-19--like symptoms alone (S0) with 3 strategies of testing: (S1) key workers with COVID-19--like symptoms in isolation, (S2) key workers without COVID-19--like symptoms but in household quarantine due to exposure to symptomatic household contacts, and (S3) one-off testing all key workers, including those without COVID-19--like symptoms or household exposure.

In addition, we explored 5 confirmatory re-testing scenarios for each strategy: repeating (A) all initial tests, (B) initially positive tests \[[@CIT0018]\], (C) initially negative tests, (D) no re-testing \[[@CIT0005], [@CIT0018], [@CIT0019]\], or (E) no re-testing but additional isolation for 2 weeks for laboratory-confirmed cases without severe symptoms \[[@CIT0001]\] ([Table 1](#T1){ref-type="table"}, [Figure 1](#F1){ref-type="fig"}).

###### 

Strategies of Testing Key Workers for Infection With SARS-CoV-2 to Enable Them to Return to Work as Soon as Possible While Minimizing the Risk of Transmission

      Population of Key Workers Tested               (Re-)Testing Scenarios                     
  --- ---------------------------------- ----- ----- ------------------------ ----- ----- ----- -----
  0   No                                 No    No    n/a                      n/a   n/a   n/a   n/a
  1   Yes                                No    No    1A                       1B    1C    1D    1E
  2   No                                 Yes   No    2A                       2B    2C    2D    2E
  3   Yes                                Yes   Yes   3A                       3B    3C    3D    3E

Strategy 0 assumes no testing is performed. In line with guidance \[[@CIT0005], [@CIT0011]\], strategy 1 explored testing key workers with COVID-19--like symptoms, including a new continuous cough and/or high fever \[[@CIT0003]\]. Strategy 2 explored testing key workers without symptoms but household exposure to symptomatic contacts in household quarantine (note: we explored testing the symptomatic household contact of the key worker as the index case who required the household to quarantine in scenario analysis; see [Supplementary Figure 2](#sup1){ref-type="supplementary-material"}). Strategy 3 explored testing all key workers, including one-off testing of key workers without symptoms or household exposure and not in quarantine/isolation, to identify infections and then isolate infected workers. The letters correspond to the 5 confirmatory testing scenarios (A--E), including the WHO recommendation for mild laboratory-confirmed cases to isolate for an additional 2 weeks where confirmatory testing is not possible \[[@CIT0001]\]. Note: "Isolation" refers to symptomatic cases, while "quarantine" refers to individuals who are not currently infectious and show no symptoms (yet) but may have been exposed to symptomatic household contacts and so might be infected and might become infectious. Where we need an umbrella term to refer to some people who are sick and others who are not we use the term isolation.

Abbreviations: COVID-19, coronavirus diseasea 2019; n/a, not applicable; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2; WHO, World Health Organization.

![Model decision tree of the explored testing strategies in key workers for infection with SARS-CoV-2, and the assumed absence durations (in days). For a technical description of the underlying model accounting for test sensitivity and specificity see [Supplementary Figure 1](#sup1){ref-type="supplementary-material"}. Abbreviations: COVID-19, coronavirus disease 2019; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2.](ciaa901f0001){#F1}

For strategy S2, we also explored in a separate scenario analysis testing the symptomatic household contact of the key worker in household quarantine (as the index case who required the household to quarantine).

Assumed Absence Durations Informing the Model {#s4}
---------------------------------------------

International guidance recommends key workers with COVID-19--like symptoms to self-isolate for 7 days, and workers in household quarantine for 14 days \[[@CIT0001], [@CIT0003]\]. We assumed symptomatic workers who tested negative to self-isolate for 3 days on account of their presumed non--COVID-19 acute respiratory illness \[[@CIT0020]\]. Symptomatic workers in symptomatic households are assumed to stay an additional 2 days at home (for an equal chance of who became symptomatic first \[[@CIT0021], [@CIT0022]\]). Key workers in household quarantine who tested negative are assumed to self-isolate for 7 days until the infectivity of the case at home is assumed to have ended \[[@CIT0014]\]. We explored different values for the durations in isolation and quarantine in sensitivity analyses (for more details, see [Figure 1](#F1){ref-type="fig"} and [Supplementary Table 1](#sup1){ref-type="supplementary-material"}).

RESULTS {#s5}
=======

With the baseline strategy of no testing and self-isolating based on COVID-19--like symptoms alone (S0), we expect 987--2267 days lost in isolation and 0.562--104.1 infected workers with the potential to spread per 1000 key workers. Testing strategies S1 and S2 are expected to reduce the total number of days of the absence durations, while S3 may increase it ([Table 2](#T2){ref-type="table"}). Conversely, strategies S1 and S2 may increase the total number of infected workers remaining at work, while S3 may reduce it ([Table 2](#T2){ref-type="table"}). The total number of tests for the 1000 key workers varies per testing strategy and re-testing scenario as is shown in [Table 2](#T2){ref-type="table"}.

###### 

Model Results for SARS-CoV-2 Testing in 1000 Key Workers, Including the Ranges of the Uncertainty of Infected Workers, Proportion Asymptomatic, Specificity, and Sensitivity

  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Strategy   Number of Tests (per 1000 Workers)               Days in Isolation\              Workers Spreading\               Efficiency Compared With No Testing, S0                                          Testing Accuracy   
                                                              (per 1000 Workers)              (per 1000 Workers)                                                                                                                   
  ---------- ------------------------------------ ----------- -------------------- ---------- -------------------- ----------- ----------------------------------------- ----------- ------------- ------------ ------------------ -----------
  S0         0.0                                  0.0         987                  2267       0.562                104.1       n/a                                       n/a         n/a           n/a          n/a                n/a

  S1A        92.8                                 219.6       804                  2049       0.653                122.4       −1.97                                     −1.00       0.983         83.048       0.831              0.988

  S1B        51.3                                 168.2       **802**              **1993**   0.722                136.0       −3.60                                     −1.63       3.113         189.750      0.709              **0.996**

  S1C        87.6                                 161.2       823                  2118       **0.585**            **108.7**   −1.87                                     −0.93       **0.195**     **28.283**   **0.884**          0.991

  S1D        **46.4**                             **109.8**   821                  2062       0.653                122.4       −**3.58**                                 **−1.87**   1.966         166.096      0.800              0.965

  S1E        **46.4**                             **109.8**   821                  2062       0.653                122.4       −**3.58**                                 **−1.87**   1.966         166.096      0.800              0.965

  S2A        93.9                                 210.4       661                  1612       0.569                107.7       −3.47                                     −3.12       0.078         16.801       **0.958**          0.997

  S2B        51.7                                 124.9       **658**              1587       0.575                110.3       −6.89                                     −5.44       0.247         49.525       0.940              **0.999**

  S2C        89.2                                 190.7       694                  1693       **0.564**            **105.0**   −3.48                                     −3.01       **0.017**     **4.635**    0.890              **0.999**

  S2D        **47.0**                             **105.2**   691                  1669       0.569                107.7       −**6.93**                                 **−5.69**   0.155         33.603       0.880              0.997

  S2E        **47.0**                             **105.2**   754                  1945       0.569                107.7       −6.80                                     −3.07       0.155         33.603       0.880              0.997

  S3A        1979.2                               1995.9      611                  2580       0.239                47.8        −0.22                                     0.16        −28.455       −0.162       **0.944**          0.995

  S3B        1011.5                               1212.8      **491**              **2142**   0.418                83.7        −**0.47**                                 **−0.10**   −16.876       0.971        0.915              **0.999**

  S3C        1756.0                               1980.0      712                  3934       **0.048**            **11.9**    −0.20                                     0.95        −52.488       −0.265       0.890              **0.999**

  S3D        **989.6**                            **998.0**   676                  3495       0.239                47.8        −0.44                                     1.24        −**56.909**   −**0.324**   0.871              0.995

  S3E        **989.6**                            **998.0**   801                  5803       0.239                47.8        −0.31                                     3.57        −**56.909**   −**0.324**   0.871              0.995
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Highlighting per testing strategy in bold: Lowest number of tests, days in isolation, and workers spreading (per 1000 tests); highest reduction/lowest increase of days in isolation, highest reduction/lowest increase of workers spreading (per 1000 tests), highest accuracy.

Abbreviations: Max, maximum; Min, minimum; n/a, not applicable; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2.

Efficiency of Testing Strategies as Compared With No Testing (S0) {#s6}
-----------------------------------------------------------------

In order to optimize the testing strategies in reducing staff absences and workplace transmission risk it is important to consider the efficiency of the number of tests performed. [Figures 2](#F2){ref-type="fig"} and [3](#F3){ref-type="fig"} present the main findings for the 3 different testing strategies (S1--S3) in terms of changes in absence duration and the transmission risk per test against the baseline of no testing (S0). Note that negative values of change thus represent desirable reductions (in transmission risk or days in isolation; indicated in white-shaded areas). Also, the impact of the variation in key epidemiological parameters (the proportion of infected workers and asymptomatic in [Figure 2](#F2){ref-type="fig"} and the RT-PCR specificity and sensitivity in [Figure 3](#F3){ref-type="fig"}) is illustrated with the different sizes and fading of the shapes, with smaller shapes that are fading out representing increasing parameter values. All other parameters were kept at their base value, and their impact on results are presented in the [Supplementary Material](#sup1){ref-type="supplementary-material"} and discussed below (note that the variation of results for all other disease parameters is captured within the range of these 4 key parameters).

![Change in the days in self-isolation and the transmission risk per test (in rows), shown per strategy (in columns) for different proportions of SARS-CoV-2--infected workers and asymptomatic SARS-CoV-2 infection. Note that negative values of changes represent desirable reductions. Abbreviations: COVID-19, coronavirus disease 2019; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2.](ciaa901f0002){#F2}

![Change in the days in self-isolation and the transmission risk per test (in rows), shown per strategy (in columns) for different proportions of RT-PCR specificity and sensitivity. Note that negative values of changes represent desirable reductions. Abbreviations: COVID-19, coronavirus disease 2019; RT-PCR, reverse transcriptase--polymerase chain reaction.](ciaa901f0003){#F3}

Testing workers with COVID-19--like symptoms (S1) may reduce absences by 0.9--3.6 days per test for those uninfected with SARS-CoV-2 or with false-negative results; the latter may increase transmission risk to others when back at work by 0.2--189.8 infected workers per 1000 tests (depending on the rate of infection) ([Figure 2](#F2){ref-type="fig"}). Re-testing negatives (S1C) increases the transmission risk the least (0.2--28.3 workers per 1000 tests) ([Figure 2](#F2){ref-type="fig"}), while still reducing absence durations (0.9--1.9 days). The number of tests is the second highest (87.6--161.2 tests per 1000 workers) at an accuracy of 88.4--99.1% ([Table 2](#T2){ref-type="table"}).

Similarly, testing workers in household quarantine (S2) may reduce absences by 3.0--6.9 days per test but increase transmission risk to others by 0.02--49.5 workers per 1000 tests ([Figure 2](#F2){ref-type="fig"}). Re-testing negatives (S2C) increases the transmission risk the least (0.02--4.6 workers per 1000 tests), while reducing absence durations (3.0--3.5 days per test), at 89.2--190.7 tests per 1000 workers and an accuracy of 89.0--99.9% ([Table 2](#T2){ref-type="table"}).

Testing all key workers (S3) may change absence durations between −0.5 and +3.6 days per test, largely due to finding asymptomatic infections and false-positive results. It changes the transmission risk between −56.9 and +0.97 workers per 1000 tests ([Figure 2](#F2){ref-type="fig"}), with an increased risk of workplace transmission only at low sensitivity of 60% and when re-testing positives (S3B). The accuracy (87.1--99.9%) and testing needs (989.6--1995.9 tests per 1000 workers) are high.

Sensitivity Analyses {#s7}
--------------------

The reductions in absence were most sensitive to the test specificity (affecting false-positives) ([Figure 3](#F3){ref-type="fig"}, the vertical dispersion of values), while transmission risk was most sensitive to the rate of infection (affecting numbers of infections) ([Figure 2](#F2){ref-type="fig"}). The accuracy was most dependent on the positive-predictive value of testing strategies ([Supplementary Table 2](#sup1){ref-type="supplementary-material"}, [Supplementary Figures 3 and 4](#sup1){ref-type="supplementary-material"}). If the proportion of infections that are asymptomatic is higher and there are fewer symptomatic cases, then fewer individuals are expected to isolate at home even in the baseline scenario without testing, which, in turn, changes the number of staff who are being tested by the different testing strategies. This difference between testing strategies and the baseline of no-testing may lead to nonproportional changes in the efficiency of testing, and hence small variation in results even when testing all staff ([Figure 2](#F2){ref-type="fig"}).

The sensitivity of the other parameters showed that none of the rates of illness changed results beyond the impact of the 4 key epidemiological parameters; more extreme numbers of days spent in isolation may be less plausible, but they would lead to largely different absence durations ([Supplementary Figures 5--8](#sup1){ref-type="supplementary-material"}). Our separate scenario analysis of testing the symptomatic index case in households in quarantine increases the number of tests, which decreases the magnitude of the outcomes but not their direction ([Supplementary Figure 2](#sup1){ref-type="supplementary-material"}).

DISCUSSION {#s8}
==========

Self-isolation depletes the supply of key workers essential during the COVID-19 pandemic and whose work is valued very highly \[[@CIT0023], [@CIT0024]\]. For example, with public services in healthcare under pressure from COVID-19 internationally, maximizing the availability of staff is critical. Our model results indicate that, as compared with no testing (S0), testing all workers (S3) may reduce the risk of workplace transmission the most by finding asymptomatic infections (particularly at an RT-PCR sensitivity of ≥65%), but with increased staff absences and greatly increased testing capacity needs. In contrast, testing workers in quarantine (S2) reduces absence durations the most by identifying those who are not SARS-CoV-2 infected, allowing some of these staff to return to work earlier than without testing but at an increased risk of workplace transmission. This risk can be mitigated but not eliminated through re-testing initially negative samples for staff in quarantine (S2C).

The optimal testing strategy will be context dependent and setting specific, and also depends on the risk of workplace exposure, the levels of infection that will differ by occupation and during the course of the epidemic, the availability of testing capacity and resources, and the relative weight given to reducing staff absences (which may be valued higher during staff shortages) and reducing transmission risk to others (which may be valued higher for frontline healthcare staff working with vulnerable individuals in hospitals and care homes). It will also differ for frontline workers in frequent contact with vulnerable individuals versus those in important supporting roles in the back office, which carry a lower risk of exposure. For instance, strategy S3 might be targeted at workers who contact vulnerable individuals such as immunocompromised patients or nursing-home residents. Weekly testing of asymptomatic workers could be considered for those who have never been tested before (where the chance of being positive equals the prevalence) or for workers who tested negative a week ago (where the chance of being positive equals the risk of being infected in the last 7 days).

Testing capacity is limited and is also required by patients. For instance, at 1 testing episode with a re-test per key worker per 3 months, testing the estimated 670 000 frontline healthcare workers in the United Kingdom \[[@CIT0025]\] requires approximately 15 000 tests per day. With approximately 11.8 million healthcare workers in the European Union and the UK \[[@CIT0026]\], capacity for more than 250 000 tests per day would be needed just to test healthcare staff (possibly increased 10-fold to capture all key workers essential to the pandemic response, as seen by the estimated 7.1 million key workers in total in the United Kingdom \[[@CIT0009]\]). Similarly, testing the 3.8 million registered nurses and physicians in the United States alone requires capacity for more than 80 000 tests per day \[[@CIT0027]\]. Given the possible shortages of laboratory supplies for extensive testing and contact tracing \[[@CIT0011], [@CIT0012]\], targeted testing thus remains important internationally. Testing healthcare workers will also remain a priority because, despite using personal protective equipment, (1) most frontline healthcare workers have a high rate of exposure to infection, due to patients with COVID-19 seeking care and due to staff being in close proximity to those patients and performing aerosol-generating procedures such as tracheal intubation/extubation \[[@CIT0028], [@CIT0029]\], and (2) infected workers are at risk of transmission to vulnerable patients (and other healthcare workers) not infected with SARS-CoV-2. However, it is important to be aware of the wide range of alternative uses for testing in the community with different resource implications---for example, screening symptomatic cases, screening their contacts, or more intensive screening in semi-enclosed settings such as care homes or prisons, etc. Quantifying these alternative uses of testing resources will be important but is outside the scope of this paper.

Strengths and Limitations {#s9}
-------------------------

This rapid analysis was based on the known epidemiology of SARS-CoV-2 infection and international recommendations for self-isolation \[[@CIT0001]\]. We considered a wide range of values for all input parameters and expressed the variation in results for 1000 key workers to increase generalizability of findings and to provide insights for different audiences, reflecting the uncertainty in various occupations, activities, and settings. Furthermore, test sensitivity using swabbing and RT-PCR has been reported to be as low as 71% in hospitalized patients \[[@CIT0017]\]. However, SARS-CoV-2 causes both upper respiratory tract infection (URTI) and lower respiratory tract infection (LRTI); the latter causes pneumonia while the former will be more important for transmission and will be detected more reliably by swabbing. Therefore, swab sensitivity in hospitalized patients may be lower than in community cases of illness because hospitalized patients will be more likely to have pneumonia caused by LRTI, and some of them might have very little URTI. Also, hospitalization typically occurs after several days of illness, when viral shedding is declining (unless in the case of severe COVID-19) \[[@CIT0030]\]. Hence, swabbing may be more sensitive for detection of community cases who are a transmission risk (ie, those with URTI) than for all cases of COVID-19. It is possible that asymptomatic infection is associated with lower viral shedding, which may reduce the sensitivity of testing but which may also reduce infectivity; further research is required.

Our analysis assumes compliance with testing and with isolation/quarantine rules. Noncompliance would reduce the beneficial effects of testing. However, noncompliance with testing of symptomatic cases would require hiding of symptoms from colleagues; noncompliance with screening of asymptomatic individuals would be even harder if all staff are required to be tested; and noncompliance with staying at home for the required isolation/quarantine period by those who test positive would be difficult if staff are not allowed to work. Noncompliance with household quarantine (ie, staying at home due to a household member's illness) may be easier to achieve because it simply requires nondisclosure, but it may be less likely to occur with healthcare workers who are motivated to care for patients. Furthermore, people evading household quarantine and attending work would have done so in the absence of a testing strategy, and infection could be found by asymptomatic screening. Those required to stay at home may choose to leave their home for shopping, leisure, or socializing, and thus transmit infection in the community, but this is not the focus of our analysis.

We did not model transmission dynamics to calculate numbers of transmission events because this is highly context dependent and requires knowledge of transmission probabilities per contact (by type of contact), rates of contact (by type of contact), mixing patterns (ie, characteristics of individuals with whom contact is made), etc. Hence, we report on the change in transmission risk from infected workers returning to work, which we acknowledge may underestimate transmission reductions from finding asymptomatic infection and transmission increases from releasing false-negatives from isolation or household quarantine. Findings for strategy S3 could thus lead to shorter absence durations but at increased transmission risks, and additional labor shortages as a result from secondary infections of infected workers returning to work. Other benefits of testing, such as reduced anxiety \[[@CIT0007], [@CIT0013]\] and improved surveillance, were not explicitly included in our analysis. Additional occupational measures will also be needed to protect, maintain, and restore the physical and mental health of key workers \[[@CIT0031], [@CIT0032]\].

Conclusions {#s10}
-----------

Our model results suggest the largest reduction of days in isolation at minimally increased transmission risk when testing key workers in household quarantine for SARS-CoV-2 infection as compared with no testing and self-isolating based on COVID-19--like symptoms alone, or if capacity allowed, testing all staff if preventing workplace transmission is paramount.

Supplementary Data {#s11}
==================

Supplementary materials are available at *Clinical Infectious Diseases* online. Consisting of data provided by the authors to benefit the reader, the posted materials are not copyedited and are the sole responsibility of the authors, so questions or comments should be addressed to the corresponding author.

###### 

Click here for additional data file.
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